Could a single shot slow knee arthritis? early trial halted
NCT ID NCT03706521
Summary
This study tested an experimental injection called lorecivivint for people with painful knee osteoarthritis. The main goal was to see if the injection could improve the health of knee cartilage, measured by MRI scans over one year. The trial was small and ended early due to COVID-19 disruptions, so no final results are available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.